Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S L Berg

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Journal of Pediatric Hematology/Oncology|February 25, 1999
Pharmacokinetics and cerebrospinal fluid penetration of daunorubicin, idarubicin, and their metabolites in the nonhuman primate modelS L Berg, J Reid, K Godwin, et al.
Cancer Chemotherapy and Pharmacology|June 8, 2001
Plasma and cerebrospinal fluid pharmacokinetics of gemcitabine after intravenous administration in nonhuman primatesJ Z Kerr, S L Berg, R Dauser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
Phase I trial and pharmacokinetic study of pyrazoloacridine in children and young adults with refractory cancersS L Berg, S M Blaney, P C Adamson, et al.
Cancer Research|September 15, 1995
A phase I trial of amifostine (WR-2721) and melphalan in children with refractory cancerP C Adamson, F M Balis, J E Belasco, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2004
Phase I trial of intrathecal liposomal cytarabine in children with neoplastic meningitisL Bomgaars, J R Geyer, J Franklin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1995
Effect of R-verapamil on the pharmacokinetics of paclitaxel in women with breast cancerS L Berg, A Tolcher, J A O'Shaughnessy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1992
Phase I/II trial and pharmacokinetics of intrathecal diaziquone in refractory meningeal malignanciesS L Berg, F M Balis, S Zimm, et al.
Journal of the National Cancer Institute|January 19, 1994
Pharmacokinetics of taxol and doxorubicin administered alone and in combination by continuous 72-hour infusionS L Berg, K H Cowan, F M Balis, et al.
Cancer Research|June 1, 1993
Pharmacokinetics of piroxantrone in a phase I trial of piroxantrone and granulocyte-colony stimulating factorS L Berg, D M Savarese, F M Balis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 1997
Phase I trial and pharmacokinetic study of all-trans-retinoic acid administered on an intermittent schedule in combination with interferon-alpha2a in pediatric patients with refractory cancerP C Adamson, G Reaman, J Z Finklestein, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Journal of Pediatric Hematology/Oncology|February 25, 1999
Pharmacokinetics and cerebrospinal fluid penetration of daunorubicin, idarubicin, and their metabolites in the nonhuman primate modelS L Berg, J Reid, K Godwin, et al.
Cancer Chemotherapy and Pharmacology|June 8, 2001
Plasma and cerebrospinal fluid pharmacokinetics of gemcitabine after intravenous administration in nonhuman primatesJ Z Kerr, S L Berg, R Dauser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
Phase I trial and pharmacokinetic study of pyrazoloacridine in children and young adults with refractory cancersS L Berg, S M Blaney, P C Adamson, et al.
Cancer Research|September 15, 1995
A phase I trial of amifostine (WR-2721) and melphalan in children with refractory cancerP C Adamson, F M Balis, J E Belasco, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2004
Phase I trial of intrathecal liposomal cytarabine in children with neoplastic meningitisL Bomgaars, J R Geyer, J Franklin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1995
Effect of R-verapamil on the pharmacokinetics of paclitaxel in women with breast cancerS L Berg, A Tolcher, J A O'Shaughnessy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1992
Phase I/II trial and pharmacokinetics of intrathecal diaziquone in refractory meningeal malignanciesS L Berg, F M Balis, S Zimm, et al.
Journal of the National Cancer Institute|January 19, 1994
Pharmacokinetics of taxol and doxorubicin administered alone and in combination by continuous 72-hour infusionS L Berg, K H Cowan, F M Balis, et al.
Cancer Research|June 1, 1993
Pharmacokinetics of piroxantrone in a phase I trial of piroxantrone and granulocyte-colony stimulating factorS L Berg, D M Savarese, F M Balis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 1997
Phase I trial and pharmacokinetic study of all-trans-retinoic acid administered on an intermittent schedule in combination with interferon-alpha2a in pediatric patients with refractory cancerP C Adamson, G Reaman, J Z Finklestein, et al.
Pageof 4